{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:13:53Z","timestamp":1761513233143,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T00:00:00Z","timestamp":1357776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00408-012-9444-2","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T12:02:59Z","timestamp":1357732979000},"page":"135-146","source":"Crossref","is-referenced-by-count":7,"title":["Safety and Efficacy of 12-Week or Longer Indacaterol Treatment in Moderate-to-Severe COPD Patients: A Systematic Review"],"prefix":"10.1007","volume":"191","author":[{"given":"Fa-Ming","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zong-An","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao-Ling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,10]]},"reference":[{"unstructured":"World Health Organisation (WHO) World Health Statistics. Available at: http:\/\/www.who.int\/whosis\/whostat\/EN WHS08 Full.pdf","key":"9444_CR1"},{"unstructured":"Global initiative for chronic obstructive lung disease (GOLD) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2011. Available at: www.goldcopd.com","key":"9444_CR2"},{"unstructured":"Food and Drug Administration (FDA) FDA approves Arcapta Neohaler to treat chronic obstructive pulmonary disease. Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm261649.htm","key":"9444_CR3"},{"key":"9444_CR4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/15412555.2010.528812","volume":"7","author":"B Maele","year":"2010","unstructured":"Maele B, Fabbri LM, Martin C, Horton R, Dolker M, Overend T (2010) Cardiovascular safety of QVA149, a combination of indacaterol and NVA237, in COPD patients. COPD 7:418\u2013427. doi: 10.3109\/15412555.2010.528812","journal-title":"COPD"},{"doi-asserted-by":"crossref","unstructured":"Vogelmeier C, Ramos-Barbon D, Jack D, Piggott S, Owen R, Higgins M et al (2010) Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium. Respir Res 11:135\u2013142. http:\/\/respiratory-research.com\/content\/11\/1\/135","key":"9444_CR5","DOI":"10.1186\/1465-9921-11-135"},{"key":"9444_CR6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pupt.2010.06.005","volume":"24","author":"C LaForce","year":"2011","unstructured":"LaForce C, Aumann J, Parre\u00f1o L, Iqbal A, Young D, Owen R et al (2011) Sustained 24-hour efficacy of once daily indacaterol (300\u00a0mg) in patients with chronic obstructive pulmonary disease: a randomized, crossover study. Pulm Pharmacol Ther 24:162\u2013168","journal-title":"Pulm Pharmacol Ther"},{"key":"9444_CR7","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.rmed.2011.03.014","volume":"105","author":"DE O\u2019Donnell","year":"2011","unstructured":"O\u2019Donnell DE, Casaburi B, Vincken W, Puente-Maestu L, Swales J, Lawrence D et al (2011) Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respir Med 105:1030\u20131036. doi: 10.1016\/j.rmed.2011.03.014","journal-title":"Respir Med"},{"key":"9444_CR8","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.rmed.2010.08.010","volume":"104","author":"H Magnussen","year":"2010","unstructured":"Magnussen H, Verkindre C, Jack D, Jadayel D, Henley M, Woessner R et al (2010) Indacaterol once a day is equally effective dosed in the evening or morning in COPD. Respir Med 104:1869\u20131876. doi: 10.1016\/j.rmed.2010.08.010","journal-title":"Respir Med"},{"key":"9444_CR9","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/thx.2010.139113","volume":"65","author":"JA Noord van","year":"2010","unstructured":"van Noord JA, Buhl R, LaForce C, Martin C, Jones F, Dolker M et al (2010) QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease. Thorax 65:1086\u20131091. doi: 10.1136\/thx.2010.139113","journal-title":"Thorax"},{"key":"9444_CR10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.pupt.2006.09.001","volume":"20","author":"J Beier","year":"2007","unstructured":"Beier J, Chanez P, Martinot J-B, Schreurs AJ, Tkacova R, Bao W et al (2007) Safety, tolerability and efficacy of indacaterol, a novel once a day b2-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial. Pulm Pharmacol Ther 20:740\u2013749. doi: 10.1016\/j.pupt.2006.09.001","journal-title":"Pulm Pharmacol Ther"},{"key":"9444_CR11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/15412555.2011.594464","volume":"8","author":"K-M Beeh","year":"2011","unstructured":"Beeh K-M, Wagner F, Khindri S, Drollmann AF (2011) Effect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPD. COPD 8:340\u2013345. doi: 10.3109\/15412555.2011.594464","journal-title":"COPD"},{"key":"9444_CR12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pupt.2010.01.003","volume":"23","author":"PJ Barnes","year":"2010","unstructured":"Barnes PJ, Pocock SJ, Magnussen H, Iqbal A, Kramer B, Higgins M et al (2010) Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design. Pulm Pharmacol Ther 23:165\u2013171. doi: 10.1016\/j.pupt.2010.01.003","journal-title":"Pulm Pharmacol Ther"},{"key":"9444_CR13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.rmed.2008.02.001","volume":"102","author":"S Rennard","year":"2008","unstructured":"Rennard S, Bantje T, Centanni S, Chanez P, Chuchalin A, Chuchalin A et al (2008) A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison. Respir Med 102:1033\u20131044. doi: 10.1016\/j.rmed.2008.02.001","journal-title":"Respir Med"},{"key":"9444_CR14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.rmed.2011.02.008","volume":"105","author":"S Korn","year":"2011","unstructured":"Korn S, Kerwin E, Atis S, Amos C, Owen R, Lassen C et al (2011) Indacaterol once a day provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study. Respir Med 105:719\u2013726. doi: 10.1016\/j.rmed.2011.02.008","journal-title":"Respir Med"},{"doi-asserted-by":"crossref","unstructured":"Feldman G, Siler T, Prasad N, Jack D, Piggott S, Owen R et al (2010) Efficacy and safety of indacaterol 150 microg once a day in COPD: a double-blind, randomised, 12-week study. BMC Pulm Med 10:11\u201319. http:\/\/dx.doi.org\/10.1186\/1471-2466-10-11","key":"9444_CR15","DOI":"10.1186\/1471-2466-10-11"},{"doi-asserted-by":"crossref","unstructured":"Donohue JF, Fogarty C, L\u00f6tvall J, Mahler DA, Worth H, Yorganciog \u02d8lu A et al (2010) Once a day bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med 182(2):155\u2013162. http:\/\/dx.doi.org\/10.1164\/rccm.200910-1500OC","key":"9444_CR16","DOI":"10.1164\/rccm.200910-1500OC"},{"doi-asserted-by":"crossref","unstructured":"Dahl R, Chung KF, Buhl R, Magnussen H, Nonikov V, Jack D et al (2010) Efficacy of a new once a day long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD. Thorax 65(6):473\u2013479. http:\/\/dx.doi.org\/10.1136\/thx.2009.125435","key":"9444_CR17","DOI":"10.1136\/thx.2009.125435"},{"doi-asserted-by":"crossref","unstructured":"Kornmann O, Dahl R, Centanni S, Dogra A, Owen R, Lassen C et al (2011) Once a day indacaterol vs. twice-daily salmeterol for COPD: a placebo-controlled comparison. Eur Respir J 37:273\u2013279 http:\/\/dx.doi.org\/10.1183\/09031936.00045810","key":"9444_CR18","DOI":"10.1183\/09031936.00045810"},{"issue":"1","key":"9444_CR19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.rmed.2011.09.006","volume":"106","author":"A Rossi","year":"2011","unstructured":"Rossi A, Centanni S, Cerveri I, Gulotta C, Foresi A, Cazzola M et al (2011) Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium. Respir Med 106(1):84\u201390. doi: 10.1016\/j.rmed.2011.09.006","journal-title":"Respir Med"},{"key":"9444_CR20","first-page":"311","volume":"5","author":"B Balint","year":"2010","unstructured":"Balint B, Watz H, Amos C, Owen R, Higgins M, Kramer B et al (2010) Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol\u2013fluticasone. Int J Chron Obstruct Pulm Dis 5:311\u2013318","journal-title":"Int J Chron Obstruct Pulm Dis"},{"key":"9444_CR21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.pupt.2009.05.001","volume":"22","author":"J Beier","year":"2009","unstructured":"Beier J, Beeh K-M, Brookman L, Peachey G, Hmissi A, Pascoe S (2009) Bronchodilator effects of indacaterol and formoterol in patients with COPD. Pulm Pharmacol Ther 22:492\u2013496. doi: 10.1016\/j.pupt.2009.05.001","journal-title":"Pulm Pharmacol Ther"},{"key":"9444_CR22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2332\/allergolint.10-OA-0173","volume":"59","author":"M Kato","year":"2010","unstructured":"Kato M, Makita H, Uemura K, Fukuchi Y, Hosoe M, Emery C et al (2010) Bronchodilator efficacy of single doses of indacaterol in Japanese patients with COPD: a randomised, double-blind, placebo-controlled trial. Allergol Int 59:285\u2013293. doi: 10.2332\/allergolint.10-OA-0173","journal-title":"Allergol Int"},{"issue":"2","key":"9444_CR23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1185\/03007990802675096","volume":"25","author":"O Bauwens","year":"2009","unstructured":"Bauwens O, Ninane V, Van de Maele B, Firth R, Dong F, Owen R et al (2009) 24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD: comparison with placebo and formoterol. Curr Med Res Opin 25(2):463\u2013470. doi: 10.1185\/03007990802675096","journal-title":"Curr Med Res Opin"},{"key":"9444_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1081\/COPD-200050666","volume":"2","author":"DA Mahler","year":"2005","unstructured":"Mahler DA, Witek TJ Jr (2005) The MCID of the transition dyspnea index is a total score of one unit. COPD 2:99\u2013103","journal-title":"COPD"},{"key":"9444_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1183\/09031936.03.00068503a","volume":"21","author":"TJ Witek Jr","year":"2003","unstructured":"Witek TJ Jr, Mahler DA (2003) Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J 21:267\u2013272","journal-title":"Eur Respir J"},{"doi-asserted-by":"crossref","unstructured":"Partridge MR, Miravitlles M, St\u00e5hl E, Karlsson N, Svensson K, Welte T (2010) Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD. Eur Respir J 36(1):96\u2013104. http:\/\/dx.doi.org\/10.1183\/09031936.00123709","key":"9444_CR26","DOI":"10.1183\/09031936.00123709"},{"issue":"6","key":"9444_CR27","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","volume":"55","author":"PW Jones","year":"1992","unstructured":"Jones PW, Quirk FH, Baveystock CM, Littlejohns P (1992) A self-complete measure for chronic airflow limitation: the St George\u2019s respiratory questionnaire. Am Rev Respir Dis 55(6):1321\u20131327","journal-title":"Am Rev Respir Dis"},{"key":"9444_CR28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1081\/COPD-200050513","volume":"2","author":"PW Jones","year":"2005","unstructured":"Jones PW (2005) St George\u2019s respiratory questionnaire: MCID. COPD 2:75\u201383","journal-title":"COPD"},{"issue":"6","key":"9444_CR29","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.rmed.2011.02.013","volume":"105","author":"PW Jones","year":"2011","unstructured":"Jones PW, Mahler DA, Gale R, Owen R, Kramer B (2011) Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD. Respir Med 105(6):892\u2013899","journal-title":"Respir Med"},{"issue":"4","key":"9444_CR30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4104\/pcrj.2011.00066","volume":"20","author":"PW Jones","year":"2011","unstructured":"Jones PW, Barnes N, Vogelmeier C, Lawrence D, Kramer B (2011) Efficacy of indacaterol in the treatment of patients with COPD. Prim Care Respir J 20(4):380\u2013388","journal-title":"Prim Care Respir J"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-012-9444-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-012-9444-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-012-9444-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T14:37:55Z","timestamp":1559054275000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-012-9444-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,10]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["9444"],"URL":"https:\/\/doi.org\/10.1007\/s00408-012-9444-2","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"type":"print","value":"0341-2040"},{"type":"electronic","value":"1432-1750"}],"subject":[],"published":{"date-parts":[[2013,1,10]]}}}